http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-472563-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c4cb9b5558ad97d3acc0db1113f7727
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-74
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-72
filingDate 1978-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1979-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-472563-A1
titleOfInvention PROCEDURE FOR OBTAINING 4- (QUINAZOLINIL) N-ARAL-COIL PIPERIDINES
abstract The invention relates to obtaining optically active forms of compounds of general formula I when the molecule includes at least one asymmetric carbon atom. Furthermore, when R1 is a lower alcohol radical, the carbon atom at 4 of the piperidic nucleus is asymmetric and gives rise to the formation of geometric isomers that can be separated and isolated. The compounds of general formula I, as well as their addition salts with a mineral or organic acid, are characterized by interesting pharmacological properties, in particular pronounced hypotensive properties. They show -even intravenously- a reduced toxicity and, therefore, their therapeutic margin is important.
priorityDate 1976-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581

Total number of triples: 29.